| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 45 | |
| #2 | Australia | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | Hungary | 1 | |
| #7 | Japan | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Machines | |
| #4 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pollentier Stephane | 13 |
| #2 | Borsini Franco | 11 |
| #3 | Pyke Robert | 10 |
| #4 | Evans Kenneth Robert | 9 |
| #5 | Ceci Angelo | 8 |
| #6 | Pyke Robert E | 8 |
| #7 | Friedl Thomas | 6 |
| #8 | Hanes Vladimir | 6 |
| #9 | Schindler Marcus | 5 |
| #10 | Ezhaya Antoine | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2019262336A1 | Treating sexual desire disorders with flibanserin | |
| AU2007247094A1 | Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders | |
| AU2003240672A1 | New pharmaceutical compositions containing flibanserin polymorph a | |
| BR122012029907B1 | Crystal polymorphine (form) of flibanserin 1, its use, process for preparation of flibanserin 1, and pharmaceutical compositions |